✦ LIBER ✦

Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia

✍ Scribed by Roberto Stasi; Maria Laura Evangelista; Francesco Buccisano; Adriano Venditti; Sergio Amadori

Book ID: 116395165
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 488 KB
Volume: 34
Category: Article
ISSN: 0305-7372
DOI: 10.1016/j.ctrv.2007.09.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemtuzumab ozogamicin in the treatment o

Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia

✍ Francis Giles; Elihu Estey; Susan O'Brien 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 484 KB 👁 2 views

## Abstract Gemtuzumab ozogamicin (GO) is a chemotherapeutic agent that consists of a humanized anti‐CD33 antibody (hP67.6) linked to N‐acetyl‐γ calicheamicin 1,2‐dimethyl hydrazine dichloride, a potent enediyne antitumor antibiotic. GO was approved conditionally by the Federal Drug Administration

The role of Gemtuzumab Ozogamicin in the

The role of Gemtuzumab Ozogamicin in the treatment of acute myeloid leukemia patients

✍ Pagano, L; Fianchi, L; Caira, M; Rutella, S; Leone, G 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 190 KB

High CD33-antigen loads in peripheral bl

High CD33-antigen loads in peripheral blood limit the efficacy of gemtuzumab ozogamicin (Mylotarg®) treatment in acute myeloid leukemia patients

✍ van der Velden, V H J; Boeckx, N; Jedema, I; te Marvelde, J G; Hoogeveen, P G; B 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 185 KB

Pharmacokinetics of Gemtuzumab Ozogamici

Pharmacokinetics of Gemtuzumab Ozogamicin, an Antibody-Targeted Chemotherapy Agent for the Treatment of Patients with Acute Myeloid Leukemia in First Relapse

✍ Dowell, James A.; Korth-Bradley, Joan; Liu, Hanjiu; King, S. Peter; Berger, Mark 📂 Article 📅 2001 🏛 Sage Publications 🌐 English ⚖ 109 KB

Licensure of Gemtuzumab Ozogamicin for t

Licensure of Gemtuzumab Ozogamicin for the Treatment of Selected Patients 60 Years of Age or Older with Acute Myeloid Leukemia in First Relapse

✍ Mark S. Berger; Lance H. Leopold; James A. Dowell; Joan M. Korth-Bradley; Matthe 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 141 KB

Gemtuzumab Ozogamicin (Mylotarg) for the

Gemtuzumab Ozogamicin (Mylotarg) for the Treatment of Acute Myeloid Leukemia – Ongoing Trials

✍ Gleissner, Beate ;Schlenk, Richard ;Bornhäuser, Martin ;Berdel, Wolfgang E. 📂 Article 📅 2007 🏛 S. Karger AG 🌐 English ⚖ 122 KB